Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of a set of peptide vaccine candidates for use in HLA-A31+ epithelial cancer patients.

International journal of oncology - 1 Feb 2004

Takedatsu Hiroko, Shichijo Shigeki, Azuma Kouichi, Takedatsu Hidetoshi, Sata Michio, Itoh Kyogo

Abstract excerpt

The molecular basis of host-tumor interaction in HLA-A31+ cancer patients has not been well understood. This lack of clarification is hampering the development of specific immunotherapies for these patients. This study aimed to identify a set of CTL-epitope peptides applicable for the specific im...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Vaccines
Share to Epitopes, T-Lymphocyte

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-A Antigens

Share to Immunotherapy

Share to Neoplasms, Glandular and Epithelial

Share to T-Lymphocytes, Cytotoxic

Share to Vaccines, Subunit

Source

Identifiers

PMID: 14719110

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14719110-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of a set of peptide vaccine candidates for use in HLA-A31+ epithelial cancer patients.PMID 14719110Read ↗

Identification of peptide vaccine candidates sharing among HLA-A3+, -A11+, -A31+, and -A33+ cancer patients.Semantic proximity Read ↗

The repertoire of human tumor-associated epitopes — identification and selection of antigens and their application in clinical trialsSemantic proximity Read ↗

HLA ligandome tumor antigen discovery for personalized vaccine approachSemantic proximity Read ↗

Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11+ or -A33+ allele.Semantic proximity Read ↗

Neoepitopes as Cancer Immunotherapy Targets: Key Challenges and OpportunitiesSemantic proximity Read ↗

New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.Semantic proximity Read ↗

Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T-cell receptors for cancer immunotherapy targeting hotspot driver mutationsSemantic proximity Read ↗

Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles.Semantic proximity Read ↗

Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.Semantic proximity Read ↗

About human tumor antigens to be used in immunotherapy.Semantic proximity Read ↗

Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypesSemantic proximity Read ↗

Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.